Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2016 December;57(6) > The Journal of Cardiovascular Surgery 2016 December;57(6):806-10

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEWS  NEW TOOLS IN ENDOVASCULAR SURGERY


The Journal of Cardiovascular Surgery 2016 December;57(6):806-10

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Drug-eluting stents in superficial femoral artery treatment: could they be the standard of care?

Marc BOSIERS 1, Koen DELOOSE 1, Joren CALLAERT 1, Patrick PEETERS 2, Michel BOSIERS 3

1 AZ Sint-Blasius Hospital, Dendermonde, Belgium; 2 Imelda Hospital, Bonheiden, Belgium; 3 St. Franziskus-Hospital, Münster, Germany


PDF  


Endovascular techniques have improved markedly over the past several decades. Plain old balloon angioplasty can only reach patencies around 40% after 1 year. Scaffolding stents have resulted in improved short-term results but encountered limitations for longer-term durability. With the introduction of drug-eluting technologies the process of intimal hyperplasia might be slowed, resulting in improved long-term patency results. At first, limus-eluting technologies were not able to transfer the enthusiasm from the coronaries to the infrainguinal vascular bed. However, the newer generation paclitaxel-eluting technologies perform significantly better in femoropopliteal arteries than their non-eluting or non-coated counterparts. The results of a prospective randomized trial comparing DES versus DCB is eagerly awaited. For the moment there seems, based on the meta-analysis, no difference between the two treatment modalities. Although, we need to keep in mind that DCB perform worse in long calcified lesions.

top of page

Publication History

Cite this article as

Bosiers M, Deloose K, Callaert J, Peeters P, Bosiers M. Drug-eluting stents in superficial femoral artery treatment: could they be the standard of care? J Cardiovasc Surg 2016 December;57(6):806-10. 

Corresponding author e-mail

marc.bosiers@telenet.be